Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2220-2224

  Ferro, Beatriz E ^a   García, Pamela K ^a   Nieto, Luisa Maria ^a   Van Soolingen, Dick ^b,c  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC RESISTANCE TEST; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COLOMBIA; CONTROLLED STUDY; EMBB GENE; GENE MUTATION; GENOTYPE; GYRA GENE; INHA GENE; KATG GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; RRS GENE; SENSITIVITY AND SPECIFICITY; DRUG EFFECTS; EVALUATION STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PROCEDURES; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COLOMBIA; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84879444317     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00429-13     Document Type: Article

References (27)

1. WHO. 2008. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy statement. World Health Organization, Geneva, Switzerland.
2. Hillemann D, Rüsch-Gerdes S, Richter E. 2007. Evaluation of the Geno-TypeMTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640.
3. Evans J, Stead MC, Nicol MP, Segal H. 2009. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. J. Antimicrob. Chemother. 63:11-16.
4. Huang WL, Chen HY, Kuo YM, Jou R. 2009. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 47:2520-2524.
5. Hillemann D, Rüsch-Gerdes S, Richter E. 2009. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47:1767-1772.
6. Dobner P, Bretzel G, Rüsch-Gerdes S, Feldmann K, Rifai M, Löscher T, Rinder H. 1997. Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. Mol. Cell. Probes 11:123-126.
7. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca LS, Ho JL, Kritski AL, Rossetti MLR. 2009. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 19: 9-39.
8. Kent PT, Kubica GP. 1985. Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control and Prevention, Atlanta, GA.
9. Moreira CA, Hernández HL, Arias NL, Castaño MC, Ferro BE, Jaramillos E. 2004. Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia. Biomedica 24(Supp 1):73-79. (In Spanish.)
10. Ferro BE, Nieto LM, Rozo JC, Forero L, van Soolingen D. 2011. Multidrug-resistant Mycobacterium tuberculosis, southwestern Colombia. Emerg. Infect. Dis. 17:1259-1262.
11. Nieto LM, Ferro BE, Villegas SL, Mehaffy C, Forero L, Moreira C, Rastogi N, van Soolingen D. 2012. Characterization of extensively drug resistant tuberculosis (XDR-TB) cases from Valle del Cauca, Colombia. J. Clin. Microbiol. 50:4185-4187.
12. Zenteno-Cuevas R, Zenteno JC, Cuellar A, Cuevas B, Sampieri CL, Riviera JE, Parissi A. 2009. Mutations in rpoB and katG genes in Mycobacterium isolates from the southeast of Mexico. Mem. Inst. Oswaldo Cruz 104:468-472.
13. Cardoso RF, Cooksey RC, Morlock GP, Barco P, Cecon L, Forestiero F, Leite CQF, Sato DN, de Lourdes Shikama M, Mamizuka EM, Hirata RDC, Hirata MH. 2004. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Chemother. 48:3373-3381.
14. Asencios L, Galarza M, Quispe N, Vásquez L, Leo E, Valencia E, Ramírez J, Acurio M, Salazar R, Mendoza-Ticona A, Cáceres O. 2012. Prueba molecular GenoType MTBDRplus, una alternativa para la detección rápida de tuberculosis multidrogorresistente. Rev. Peru. Med. Exp. Salud Publica 29:92-98.
15. Araya P, Velasco M, Tognarelli J, Arias F, Leiva T, Sccapatticio A, Alviz P, Fernández J. 2011. Detección de mutaciones asociadas a cepas multidrogo resistente de Mycobacterium tuberculosis en Chile. Rev. Méd. Chile 139:467-473. (In Spanish.)
16. Vasquez Michel AM, Camacho M, Molina J. 2011. Molecular and bacteriological analysis of rifampin-resistant Mycobacteryum [sic] tuberculosis isolated from seven regions of Bolivia. Biofarbo 19:21-27.(In Spanish.)
17. Brossier F, Veziris N, Jarlier V, Sougakoff W. 2009. Performance of MTBDRplus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int. J. Tuberc. Lung Dis. 13:260-265.
18. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. 2006. Use of GenoType MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J. Clin. Microbiol. 44:2485-2491.
19. Cavusoglu C, Turhan A, Akinci P, Soyler I. 2006. Evaluation of the GenoType MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44: 2338-2342.
20. Causse M, Ruiz P, Gutierrez JB, Zerolo J, Casal M. 2008. Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 12:1456-1460.
21. Kiet VS, Lan NTN, An DD, Dung NH, Hoa DV, van Vinh Chau N, Chinh NT, Farrar J, Caws M. 2010. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 48:2934-2939.
22. Nikolayevskyy V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F. 2009. Performance of the GenoType MTBDRplus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin. Pathol. 9:2. doi:10.1186/1472-6890-9-2.
23. Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. 2012. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. BMC Infect. Dis. 12:37. doi:10.1186/1471-2334-12-37.
24. Huyen MNT, Tiemersma EW, Lan NTN, Cobelens FGJ, Dung NH, Sy DN, Buu TN, Kremer K, Hang PT, Caws M, O'Brien R, van Soolingen D. 2010. Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect. Dis. 10:149. doi:10.1186/1471-2334-10-149.
25. Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. 2012. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 7:e33275. doi:10.1371/journal.pone.0033275.
26. Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. 2012. Evaluation of the GenoType MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. Int. J. Tuberc. Lung Dis. 16:104-109.
27. Hofmann-Thiel S, van Ingen J, Feldmann K, Turaev L, Uzakova GT, Murmusaeva G, van Soolingen D, Hoffmann H. 2009. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur. Respir. J. 33:368-374.